NC_045512v2	21766	21772	H69-	0	.	21766	21772	0,0,255	2020-01-05	hodcroftlab	May alter the recognition by antibodies, possibly impacting some antibody-therapy treatments, or immunity. In one study, was identified as a 'recurrent deletion region' (found multiple times in public sequences), but did not impact the 2 monoclonal antibodies tested.	n/a	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/S.H69-_table.md	https://nextstrain.org/groups/neherlab/ncov/S.H69-?c=gt-S_69,501,453	https://www.medrxiv.org/content/10.1101/2020.12.05.20241927v2, https://www.biorxiv.org/content/10.1101/2020.12.14.422555v3, https://www.biorxiv.org/content/10.1101/2020.11.19.389916v1
NC_045512v2	21799	21802	D80Y	0	.	21799	21802	128,0,128	20-07-16	hodcroftlab	n/a	Found in at least 10 countries across Europe	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/S.D80Y_table.md	https://nextstrain.org/groups/neherlab/ncov/S.D80Y?f_region=Europe	https://www.biorxiv.org/content/10.1101/2020.05.01.072330v1
NC_045512v2	21853	21856	S98F	0	.	21853	21856	0,0,255	2020-03-21	hodcroftlab	n/a	Mostly found in Belgium and the Netherlands - predominantly Belgium	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/S.S98F_table.md	https://nextstrain.org/groups/neherlab/ncov/S.S98F?c=gt-S_98&f_region=Europe	n/a
NC_045512v2	22225	22228	A222V	0	.	22225	22228	0,0,255	2020-06-01	hodcroftlab	Mutation in the non-terminal domain (NTD), which is not known to play a direct role in receptor binding or membrane fusion. Subclade 20A. EU1, lineage B.1.177	Associated with a cluster that initially expanded in Spain and spread across Europe via holiday travel	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/20A.EU1_table.md	https://nextstrain.org/groups/neherlab/ncov/20A.EU1?f_region=Europe	https://www.medrxiv.org/content/10.1101/2020.10.25.20219063v2
NC_045512v2	22876	22879	N439K	0	.	22876	22879	0,0,255	2020-05-13	hodcroftlab	Mutation is in the receptor binding domain (RDB), important to ACE2 binding and antibody recognition. May increase ACE2 binding. Confers resistance to one of the two antibodies in the Regeneron cocktail (REGN10987). 	Has emerged twice independently in Europe, but was exclusive to Scotland in the first wave and went extinct		https://nextstrain.org/groups/neherlab/ncov/S.N439K?c=gt-S_439&f_region=Europe	https://www.sciencedirect.com/science/article/pii/S0022283620304563, https://www.biorxiv.org/content/10.1101/2020.11.30.405472v1.full, https://elifesciences.org/articles/61312, https://www.nature.com/articles/s41586-020-2852-1
NC_045512v2	22918	22921	Y453F	0	.	22918	22921	0,0,255	2020-04-25	hodcroftlab	May be a mink-specific adaptation, increasing binding to mink ACE2. May also increase ACE2 binding in humans. Does confer resistance to an antibody in the Regeneron cocktail: REGN10933.	Associated with the 'cluster 5' 'mink' variant in Denmark and the Netherlands.		https://nextstrain.org/groups/neherlab/ncov/netherlands?c=gt-S_453&f_country=Netherlands&f_host=Mink	https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1008449, https://science.sciencemag.org/content/369/6506/1014/tab-pdf, https://www.biorxiv.org/content/10.1101/2020.11.30.405472v1.full
NC_045512v2	22990	22993	S477N	0	.	22990	22993	128,0,128	2020-07-09	hodcroftlab	Mutation is in the receptor binding domain (RDB), important to ACE2 binding and antibody recognition. May slightly increase ACE2 binding. May confer resistance to multiple antibodies.  Subclade 20A.EU2.	Has arisen independently in Australia and was responsible for much of the summer 2020 outbreak	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/20A.EU2_table.md	https://nextstrain.org/groups/neherlab/ncov/20A.EU2?f_region=Europe	https://www.sciencedirect.com/science/article/pii/S0022283620304563, https://www.biorxiv.org/content/10.1101/2020.11.03.367391v1, https://www.biorxiv.org/content/10.1101/2020.11.06.372037v1
NC_045512v2	23011	23014	E484	0	.	23011	23014	0,0,255	2020-03-09	hodcroftlab	Mutations at S:E484 may significantly reduce convalescent serum neutralization. There has been a case of reinfection associated with S:E484K. 	Primarily associated with the 501Y.V2 variant that arose in South Africa in the winter of 2020 and a variant predominantly found in Brazil, but has appeared independently numerous times around the world.	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/S.E484_table.md	https://nextstrain.org/groups/neherlab/ncov/S.E484?c=gt-S_484&f_region=Europe	https://www.biorxiv.org/content/10.1101/2020.12.31.425021v1, https://www.preprints.org/manuscript/202101.0132/v1, https://www.biorxiv.org/content/10.1101/2020.12.28.424451v1
NC_045512v2	23062	23065	N501	0	.	23062	23065	0,0,255	2020-03-19	hodcroftlab	Variant of Concern.  First detected in October 2020 in the UK, correlated with significant increased rate of infection. Mutation is in the receptor binding domain (RDB), important to ACE2 binding and antibody recognition. May be associated with adaptation to rodents and mustelids; Some have speculated of risk of a persistent reservoir in wild rodents/mustelids. May increase ACE2 binding. Clades 20B/01Y.V1, 20C/01Y.V2. Lineages B.1.1.7, B.1.351	Associated with recently reported 'new variants' in the UK and South Africa. Smaller clusters also seen in Wales, USA, & Australia	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/S.N501_table.md	https://nextstrain.org/groups/neherlab/ncov/S.N501	https://www.biorxiv.org/content/10.1101/2020.12.14.422555v3, https://www.thelancet.com/article/S0140-6736(20)31757-8/fulltext, https://www.medrxiv.org/content/10.1101/2020.12.21.20248640v1, https://www.biorxiv.org/content/10.1101/2020.12.16.423118v2, https://www.biorxiv.org/content/10.1101/2021.01.07.425740v1
NC_045512v2	23401	23404	D614G	0	.	23401	23404	0,0,255	2020-03-00	Wikipeda	Initially arising in China and then spreading to Italy in January and globally from there.In July 2020, it was reported that the more infectious D614G SARS-CoV-2 variant had become the dominant form in the pandemic. The global prevalence of D614G correlates with the prevalence of loss of smell as a COVID-19 symptom, possibly mediated by higher binding of the G variant to the ACE2 receptor or higher protein stability and hence higher infectivity of the olfactory epithelium.	n/a	n/a	n/a	
NC_045512v2	23437	23440	A626S	0	.	23437	23440	128,0,128	2020-07-15	hodcroftlab	n/a	Found widely across Europe, in at least 15 countries	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/S.A626S_table.md	https://nextstrain.org/groups/neherlab/ncov/S.A626S?f_region=Europe	n/a
NC_045512v2	23602	23605	P681H	0	.	23602	23605	128,0,128	2020-08-00	Wikipeda	B.1.1.207	Reported in Nigera in August 2020.	n/a	n/a	n/a
NC_045512v2	23662	23665	A701B	0	.	23662	23665	255,0,0	2020-12-23	Wikipeda	n/a	Reported in Malaysia in December 2020.	n/a	n/a	https://en.wikipedia.org/wiki/Variants_of_SARS-CoV-2#cite_note-31
NC_045512v2	24925	24928	V1122	0	.	24925	24928	128,0,128	2020-07-06	hodcroftlab	n/a	Found primarily in Sweden and northern European countries, including Norway and Denmark	https://github.com/hodcroftlab/covariants/blob/master/cluster_tables/S.V1122L_table.md	https://nextstrain.org/groups/neherlab/ncov/S.V1122L?c=gt-S_1122&f_region=Europe	n/a
